Insulet Corporation
Health
Performance
6.8
Risk
Sell
Buy
Curious about the Scores? Learn more.

Insulet Corporation stock rating and score history

All changes in ratings, performance and outlook tracked over time.

14.01.2026
On shaky ground. Struggling to find a clear direction.
23.12.2025
Momentum tanked. Clearly underperforming.
20.12.2025
Trouble brewing. Volatility and pressure rising.
20.08.2025
Health’s picking up. Numbers look cleaner, cash flow tighter.

Insulet Corporation stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Insulet Corporation do? Business model and key facts

Get the full picture of Insulet Corporation: what it builds, where it operates, and how it makes money.

Insulet Corporation Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 3900

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

shop
Company facts
Ashley A. McEvoy
CEO
3900
Employees worldwide
shop
Performance
8.36%
Last 12 months
1.88%
Last 5 years
shop
Growth
$2,07B
Revenue year
$418,30M
Net income
shop
Valuation
$20,15B
Market Cap
43.74
Price/Earnings Ratio

Stocks related to Insulet Corporation

Selected based on industry alignment and relative market positioning.

STE
STERIS plc
268.26
+1.52%
2.1
Sell
Buy
STERIS plc
DXCM
DexCom, Inc.
69.24
-0.66%
6.9
Sell
Buy
DexCom, Inc.
PHG
Koninklijke Philips N.V.
30.17
+0.23%
2.2
Sell
Buy
Koninklijke Philips N.V.
ZBH
Zimmer Biomet Holdings, Inc.
88.75
-0.55%
5.3
Sell
Buy
Zimmer Biomet Holdings, Inc.
SNN
Smith & Nephew plc
32.89
-0.09%
4.3
Sell
Buy
Smith & Nephew plc

Insulet Corporation fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.